US-based bioprocessing company Repligen Corp has announced a public offering of 2,807,017 shares priced at $42.75 each, to raise $120m.
The company plans to use the funds towards working capital and general corporate requirements, including possible acquisitions, products and technologies.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
US-based private equity firm CoBe Capital LLC plans to acquire Hill-Rom Holdings’ Volker business.
The divestiture will enable Hill-Rom to enhance its portfolio and focus on key growth platforms.
Chembio Diagnostics Inc plans to issue common stock shares to raise $21.2m.
The US-based point-of-care diagnostic tests developer plans to use the stocks for general corporate purposes.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataGlooko Inc has secured $35m through a series C financing round led by Georgian Partners.
Glooko, a US-based patient monitoring platform provider for diabetes, plans to use the funds to expand its market presence.
